losartan has been researched along with nifedipine in 76 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 15 (19.74) | 18.2507 |
2000's | 33 (43.42) | 29.6817 |
2010's | 24 (31.58) | 24.3611 |
2020's | 4 (5.26) | 2.80 |
Authors | Studies |
---|---|
Benz, RD; Contrera, JF; Kruhlak, NL; Matthews, EJ; Weaver, JL | 1 |
Andricopulo, AD; Moda, TL; Montanari, CA | 1 |
Lombardo, F; Obach, RS; Waters, NJ | 1 |
Chupka, J; El-Kattan, A; Feng, B; Miller, HR; Obach, RS; Troutman, MD; Varma, MV | 1 |
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
Chang, G; El-Kattan, A; Miller, HR; Obach, RS; Rotter, C; Steyn, SJ; Troutman, MD; Varma, MV | 1 |
Fisk, L; Greene, N; Naven, RT; Note, RR; Patel, ML; Pelletier, DJ | 1 |
Abrego, VH; Amaro-Recillas, HA; Angeles, E; Marroquín-Pascual, JL; Martínez, L; Martínez-Pérez, B; Moya-Hernández, R; Rodríguez-Barrientos, D; Rojas-Hernández, A; Rueda-Jackson, JC; Torres, LA | 1 |
Ekins, S; Williams, AJ; Xu, JJ | 1 |
Ambroso, JL; Ayrton, AD; Baines, IA; Bloomer, JC; Chen, L; Clarke, SE; Ellens, HM; Harrell, AW; Lovatt, CA; Reese, MJ; Sakatis, MZ; Taylor, MA; Yang, EY | 1 |
Cantin, LD; Chen, H; Kenna, JG; Noeske, T; Stahl, S; Walker, CL; Warner, DJ | 1 |
Aleo, MD; Bonin, PD; Luo, Y; Potter, DM; Swiss, R; Will, Y | 1 |
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
Delabio, LC; Dutra, JP; Hembecker, M; Kita, DH; Moure, VR; Pereira, GDS; Scheiffer, G; Valdameri, G; Zattoni, IF | 1 |
Lupichuk, SM; Tabrizchi, R | 1 |
Carroll, J; Grossman, E; Peleg, E; Rosenthal, T; Shamiss, A | 1 |
Hong, KW; Rhim, BY; Shin, YW; Yoo, SE | 1 |
Cox, BF; Kitzen, JM; Perrone, MH; Smits, GJ | 1 |
Abassi, ZA; Golomb, E; Keiser, HR; Klein, H | 1 |
Lambert, C | 1 |
Gelband, CH; Martens, JR; Posner, P; Sumners, C; Wang, D | 1 |
Aukland, K; Iversen, BM; Wang, X | 1 |
Angulo, J; Llergo, JL; Peiró, C; Regadera, J; Rodríguez-Mañas, L; Sánchez-Ferrer, A; Sánchez-Ferrer, CF | 1 |
Angulo, J; Llergo, JL; López-Novoa, JM; Peiró, C; Rodríguez-López, A; Rodríguez-Mañas, L; Sánchez-Ferrer, CF | 1 |
Irlbeck, M; Iwai, T; Zimmer, HG | 1 |
Barr, E; Conlin, PR; Edelman, JM; Elkins, M; Liss, C; Vrecenak, AJ | 1 |
Borges, AC; Paiva, TB; Prioste, RN; Shimuta, SI | 1 |
Dam, TV; deBlois, D; Hamet, P; Moreau, P; Tea, BS | 1 |
Black, CM; Blann, A; Bowers, E; Denton, CP; Dziadzio, M; Howell, K; Smith, R | 1 |
Langley-Evans, SC; Sherman, RC | 1 |
Doris, PA; Kähönen, M; Kalliovalkama, J; Pekki, A; Pörsti, I; Tolvanen, JP; Voipio, J; Wu, X; Ylitalo, P | 1 |
Fukumori, R; Hosokawa, H; Kambe, T; Kubo, T | 1 |
Bischoff, A; Michel, MC | 1 |
Zieleniewski, W | 1 |
Kohno, M; Masugata, H; Ohmori, K; Ohnishi, K; Takagi, Y; Wada, Y; Yukiiri, K | 1 |
Han, HJ; Park, SH | 1 |
Agabiti-Rosei, E; Rizzoni, D | 1 |
Campbell, DJ; Mackie, FE; Meyer, TW | 1 |
Kokkas, B; Kotoula, M; Kouyoumtzis, A; Mirtsou-Fidani, V; Sigalas, A | 1 |
Alvarez, BV; Cingolani, HE; De Hurtado, MC; Ennis, IL | 1 |
Adams, MA; Bushfield, TL; Hale, TM; Woolard, J | 1 |
Bendersky, M; Grassi, G; Guzman, L; Kuschnir, E; Mancia, G; Pañart, MS; Plotquin, Y; Resk, J; Wagener, G | 1 |
Beirão, PS; dos Santos, RA; Moreira, TH; Rodrigues, AL; Santos Cruz, J | 1 |
Higashiura, K; Shimamoto, K; Yoshida, D | 1 |
Ishikawa, A; Kawabe, K; Kitamura, T; Ohta, N; Ozono, S | 1 |
Anyukhovsky, EP; Danilo, P; Hefer, D; Janse, MJ; Rosen, MR; Rosen, TS; Sosunov, EA | 1 |
Balestri, G; Castiglioni, P; Centola, M; Cesana, F; Di Rienzo, M; Ferrari, AU; Radaelli, A | 1 |
Adams, MA; Hale, TM; Hannan, JL; Heaton, JP; Smallegange, C | 1 |
Weber, MA | 1 |
Chen, P; Dahl, D; Edwards, PA; Fenstermacher, JD; Guo, M; Scicli, AG; Scicli, GM | 1 |
Tinel, H | 1 |
Buzuyeva, II; Filyushina, EE; Lazarev, VA; Markel', AL; Shmerling, MD; Yakobson, GS | 1 |
Garzoni, LR; Henriques, Md; Lessa, MA; Levy, BI; Nascimento, AR; Rodrigues, CA; Sabino, B; Tibiriçá, E | 1 |
Gore, AC; Iadecola, C; Milner, TA; Pierce, JP; Speth, RC; Wang, G; Wu, D | 1 |
Harada, N; Okajima, K; Shimozawa, N | 1 |
Brody, R; Grossman, E; Peleg, E; Sharabi, Y | 1 |
Arsenault, M; Beaudoin, J; Champetier, S; Couet, J; Lachance, D; Plante, E; Roussel, E | 1 |
Ando, C; Inoue, Y; Kodama, S; Mihara, H; Miyoshi, K; Niimura, H; Okamura, K; Sumi, S; Tojyo, H; Tsuchiya, Y; Urata, H; Yamanouchi, Y | 1 |
Atar, A; Bozbaş, H; Bozbaş, SS; Oner Eyüboğlu, F; Ulubay, G | 1 |
Yilmaz, R | 1 |
Adachi, K; Furuta, K; Kinoshita, Y; Koshino, K; Miki, M; Morita, T; Nakata, S; Ohara, S; Tanimura, T; Yoshida, K | 1 |
Cameron, A; Ewen, M; Laing, RO; van Mourik, MS | 1 |
Cagnoni, F; Destro, M; Giglio, A; Grandi, AM; Lonati, L; Maresca, AM; Monza, M; Omboni, S; Parati, G; Pini, C; Ricci, AR; Venco, A | 1 |
Bundrick, JB; Litin, SC | 1 |
Akashiba, A; Furukata, S; Ishimitsu, T; Matsuoka, H; Minami, J; Nakano, N; Numabe, A; Ohno, E | 1 |
Chayama, K; Fujii, Y; Fujimura, N; Hata, T; Hidaka, T; Higashi, Y; Idei, N; Iwamoto, Y; Kato, H; Kihara, Y; Liao, JK; Maruhashi, T; Mikami, S; Noma, K; Soga, J | 1 |
Alexander, T; Baylis, C; Cunningham, MW; Fekete, A; Masilamani, SM; Sasser, JM; Shaw, S; West, CA | 1 |
D'Angelo, A; Dario Ragonesi, P; Derosa, G; Franzetti, I; Maffioli, P; Querci, F | 1 |
D'Angelo, A; Derosa, G; Franzetti, I; Maffioli, P; Mugellini, A; Pesce, RM; Querci, F | 1 |
Cicero, AF; Tocci, G | 1 |
Carvajal, L; Cifuentes, F; Morales, G; Muñoz, F; Nwokocha, CR; Palacios, J; Paredes, A | 1 |
D'Angelo, A; Derosa, G; Maffioli, P; Mugellini, A; Pesce, RM | 1 |
Kotegawa, T; Koya, Y; Machi, Y; Namiki, N; Shobu, Y; Uchida, S | 1 |
Ahmad, M; Saeed, H; Saleem, Z; Tauqeer, F; Umair, M | 1 |
Bergler-Czop, B; Brzezińska-Wcisło, L; Drobek, HH; Miziołek, B; Pietrauszka, K; Porwolik, M | 1 |
Ankrah, D; Hollingworth, SA; Okeke, CC; Ruiz, F; Thacher, E; Uzochukwu, BSC | 1 |
5 review(s) available for losartan and nifedipine
Article | Year |
---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
Targeting breast cancer resistance protein (BCRP/ABCG2): Functional inhibitors and expression modulators.
Topics: Antineoplastic Agents; ATP Binding Cassette Transporter, Subfamily G, Member 2; Breast Neoplasms; Drug Resistance, Multiple; Drug Resistance, Neoplasm; Female; Humans; Neoplasm Proteins; Neoplastic Stem Cells | 2022 |
[Treatment of hypertensive patients with impaired glucose tolerance (IGT)].
Topics: Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Arteriosclerosis; Calcium Channel Blockers; Captopril; Cardiovascular Diseases; Clinical Trials as Topic; Diabetes Mellitus; Glucose Intolerance; Humans; Hypertension; Insulin Resistance; Life Style; Losartan; Nifedipine; Risk | 2005 |
The role of the new beta-blockers in treating cardiovascular disease.
Topics: Adolescent; Adrenergic beta-Antagonists; Adult; Aged; Antihypertensive Agents; Atenolol; Benzopyrans; Cardiovascular Diseases; Clinical Trials as Topic; Enalapril; Ethanolamines; Female; Heart Failure; Hemodynamics; Humans; Hypertension; Labetalol; Losartan; Male; Metoprolol; Middle Aged; Nebivolol; Nifedipine; Receptors, Adrenergic, beta-1; Receptors, Adrenergic, beta-2; Sympathomimetics | 2005 |
What is the Best Way to Treat Patients with Raynaud's Phenomenon and a Tendency towards Hypotension?
Topics: Antihypertensive Agents; Calcium Channel Blockers; Humans; Hypotension; Losartan; Nifedipine; Nitroglycerin; Raynaud Disease; Sildenafil Citrate; Smoking Cessation; Stress, Psychological; Vasodilator Agents | 2020 |
14 trial(s) available for losartan and nifedipine
Article | Year |
---|---|
Hemodynamic and humoral effects of the angiotensin II antagonist losartan in essential hypertension.
Topics: Adult; Aldosterone; Angiotensin II; Antihypertensive Agents; Biphenyl Compounds; Blood Pressure; Body Weight; Female; Heart Rate; Hemodynamics; Humans; Hydrochlorothiazide; Hypertension; Imidazoles; Losartan; Male; Middle Aged; Neurotransmitter Agents; Nifedipine; Norepinephrine; Renin; Tetrazoles | 1994 |
A study of losartan, alone or with hydrochlorothiazide vs nifedipine GITS in elderly patients with diastolic hypertension.
Topics: Aged; Aging; Antihypertensive Agents; Calcium Channel Blockers; Diastole; Double-Blind Method; Drug Therapy, Combination; Female; Humans; Hydrochlorothiazide; Hypertension; Losartan; Male; Nifedipine; Treatment Outcome | 1998 |
Losartan therapy for Raynaud's phenomenon and scleroderma: clinical and biochemical findings in a fifteen-week, randomized, parallel-group, controlled trial.
Topics: Adult; Aged; Female; Humans; Losartan; Male; Middle Aged; Nifedipine; Pilot Projects; Raynaud Disease; Scleroderma, Systemic; Vasodilator Agents | 1999 |
Influence of the angiotensin II receptor antagonist losartan on diuretic-induced metabolic effects in elderly hypertensive patients: comparison with a calcium channel blocker.
Topics: Aged; Angiotensin Receptor Antagonists; Antihypertensive Agents; Blood Pressure; Calcium Channel Blockers; Diuretics; Dose-Response Relationship, Drug; Drug Therapy, Combination; Female; Furosemide; Humans; Hypertension; Losartan; Male; Nifedipine; Trichlormethiazide | 2001 |
Effects of the combination of low-dose nifedipine GITS 20 mg and losartan 50 mg in patients with mild to moderate hypertension.
Topics: Adult; Aged; Antihypertensive Agents; Blood Pressure; Double-Blind Method; Drug Therapy, Combination; Female; Heart Rate; Humans; Hypertension; Losartan; Male; Middle Aged; Nifedipine | 2004 |
Inhibition of plasminogen activator inhibitor-1 by angiotensin II receptor blockers on cyclosporine-treated renal allograft recipients.
Topics: Angiotensin II Type 1 Receptor Blockers; Benzimidazoles; Biphenyl Compounds; Blood Pressure; Creatinine; Cyclosporine; Female; Follow-Up Studies; Humans; Immunosuppressive Agents; Kidney Transplantation; Losartan; Male; Middle Aged; Nifedipine; Plasminogen Activator Inhibitor 1; Tetrazoles; Transplantation, Homologous | 2005 |
Additive antihypertensive and antihypertrophic effects of long-acting Ca blockers in uncontrolled hypertensive patients with angiotensin-receptor blocker based treatment.
Topics: Aged; Amlodipine; Benzimidazoles; Biphenyl Compounds; Calcium Channel Blockers; Drug Therapy, Combination; Female; Humans; Hypertension; Losartan; Male; Middle Aged; Nifedipine; Tetrazoles | 2009 |
Comparative effects of losartan and nifedipine therapy on exercise capacity, Doppler echocardiographic parameters and endothelin levels in patients with secondary pulmonary hypertension.
Topics: Aged; Angiotensin II Type 1 Receptor Blockers; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Diastole; Echocardiography, Doppler; Exercise Test; Humans; Hypertension, Pulmonary; Hypertrophy, Left Ventricular; Losartan; Middle Aged; Nifedipine; Prospective Studies; Vasodilator Agents | 2010 |
Effectiveness of barnidipine 10 or 20 mg plus losartan 50-mg combination versus losartan 100-mg monotherapy in patients with essential hypertension not controlled by losartan 50-mg monotherapy: A 12-week, multicenter, randomized, open-label, parallel-grou
Topics: Adult; Aged; Antihypertensive Agents; Blood Pressure; Calcium Channel Blockers; Dose-Response Relationship, Drug; Drug Therapy, Combination; Female; Humans; Hypertension; Losartan; Male; Middle Aged; Nifedipine | 2010 |
Combination of angiotensin II receptor antagonist with calcium channel blocker or diuretic as antihypertensive therapy for patients with chronic kidney disease.
Topics: Aged; Angiotensin Receptor Antagonists; Antihypertensive Agents; Blood Pressure; Calcium Channel Blockers; Cross-Over Studies; Diuretics; Dose-Response Relationship, Drug; Drug Therapy, Combination; Female; Glomerular Filtration Rate; Humans; Hydrochlorothiazide; Hypertension; Kidney Failure, Chronic; Losartan; Male; Middle Aged; Nifedipine; Treatment Outcome | 2011 |
Mineralocorticoid receptor blocker eplerenone improves endothelial function and inhibits Rho-associated kinase activity in patients with hypertension.
Topics: Angiotensin II Type 1 Receptor Blockers; Calcium Channel Blockers; Cell Movement; Endothelium, Vascular; Eplerenone; Female; Humans; Hypertension; Leukocytes; Losartan; Male; Middle Aged; Mineralocorticoid Receptor Antagonists; Nifedipine; Nitroglycerin; rho-Associated Kinases; Spironolactone; Stem Cells; Vascular Endothelial Growth Factor A; Vasodilation | 2012 |
Comparison of the effects of barnidipine+losartan compared with telmisartan+hydrochlorothiazide on several parameters of insulin sensitivity in patients with hypertension and type 2 diabetes mellitus.
Topics: Adipokines; Aged; Angiotensin II Type 1 Receptor Blockers; Antihypertensive Agents; Benzimidazoles; Benzoates; Calcium Channel Blockers; Diabetes Mellitus, Type 2; Diuretics; Double-Blind Method; Drug Combinations; Female; Glucose Clamp Technique; Humans; Hydrochlorothiazide; Hypertension; Insulin Resistance; Losartan; Male; Middle Aged; Nifedipine; Telmisartan | 2015 |
Barnidipine or Lercanidipine on Echocardiographic Parameters in Hypertensive, Type 2 Diabetics with Left Ventricular Hypertrophy: A Randomized Clinical Trial.
Topics: Aged; Antihypertensive Agents; Calcium Channel Blockers; Diabetes Mellitus, Type 2; Dihydropyridines; Double-Blind Method; Drug Therapy, Combination; Echocardiography; Female; Humans; Hypertension; Hypertrophy, Left Ventricular; Losartan; Male; Middle Aged; Nifedipine; Treatment Outcome | 2015 |
Barnidipine compared to lercanidipine in addition to losartan on endothelial damage and oxidative stress parameters in patients with hypertension and type 2 diabetes mellitus.
Topics: Aged; Angiotensin II Type 1 Receptor Blockers; Antihypertensive Agents; Biomarkers; Blood Pressure; Calcium Channel Blockers; Diabetes Mellitus, Type 2; Dihydropyridines; Double-Blind Method; Drug Therapy, Combination; Endothelium, Vascular; Female; Humans; Hypertension; Italy; Losartan; Male; Middle Aged; Nifedipine; Oxidative Stress; Time Factors; Treatment Outcome | 2016 |
57 other study(ies) available for losartan and nifedipine
Article | Year |
---|---|
Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling.
Topics: Adverse Drug Reaction Reporting Systems; Artificial Intelligence; Computers; Databases, Factual; Drug Prescriptions; Drug-Related Side Effects and Adverse Reactions; Endpoint Determination; Models, Molecular; Quantitative Structure-Activity Relationship; Software; United States; United States Food and Drug Administration | 2004 |
Hologram QSAR model for the prediction of human oral bioavailability.
Topics: Administration, Oral; Biological Availability; Holography; Humans; Models, Biological; Models, Molecular; Molecular Structure; Pharmaceutical Preparations; Pharmacokinetics; Quantitative Structure-Activity Relationship | 2007 |
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
Physicochemical determinants of human renal clearance.
Topics: Humans; Hydrogen Bonding; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Kidney; Metabolic Clearance Rate; Molecular Weight | 2009 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Physicochemical space for optimum oral bioavailability: contribution of human intestinal absorption and first-pass elimination.
Topics: Administration, Oral; Biological Availability; Humans; Intestinal Absorption; Pharmaceutical Preparations | 2010 |
Developing structure-activity relationships for the prediction of hepatotoxicity.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Humans; Structure-Activity Relationship; Tetracyclines; Thiophenes | 2010 |
Antihypertensive and antiarrhythmic properties of a para-hydroxy[bis(ortho-morpholinylmethyl)]phenyl-1,4-DHP compound: comparison with other compounds of the same kind and relationship with logP values.
Topics: Animals; Anti-Arrhythmia Agents; Antihypertensive Agents; Blood Pressure; Dihydropyridines; Heart Rate; Male; Morpholines; Rats; Rats, Wistar; Spectrophotometry, Ultraviolet | 2010 |
A predictive ligand-based Bayesian model for human drug-induced liver injury.
Topics: Bayes Theorem; Chemical and Drug Induced Liver Injury; Humans; Ligands | 2010 |
Preclinical strategy to reduce clinical hepatotoxicity using in vitro bioactivation data for >200 compounds.
Topics: Chemical and Drug Induced Liver Injury; Cytochrome P-450 Enzyme Inhibitors; Cytochrome P-450 Enzyme System; Decision Trees; Drug Evaluation, Preclinical; Drug-Related Side Effects and Adverse Reactions; Glutathione; Humans; Liver; Pharmaceutical Preparations; Protein Binding | 2012 |
Mitigating the inhibition of human bile salt export pump by drugs: opportunities provided by physicochemical property modulation, in silico modeling, and structural modification.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Bile Acids and Salts; Cell Line; Chemical and Drug Induced Liver Injury; Humans; Quantitative Structure-Activity Relationship | 2012 |
Human drug-induced liver injury severity is highly associated with dual inhibition of liver mitochondrial function and bile salt export pump.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Chemical and Drug Induced Liver Injury; Humans; Male; Mitochondria, Liver; Rats; Rats, Sprague-Dawley; Severity of Illness Index | 2014 |
The effects of losartan and captopril on vasopressor actions of cirazoline in the absence and presence of SZL-49 and nifedipine.
Topics: Adrenergic alpha-Agonists; Adrenergic alpha-Antagonists; Analysis of Variance; Animals; Antihypertensive Agents; Biphenyl Compounds; Blood Pressure; Captopril; Decerebrate State; Dose-Response Relationship, Drug; Imidazoles; Infusions, Intra-Arterial; Infusions, Intravenous; Losartan; Male; Nifedipine; Prazosin; Rats; Rats, Sprague-Dawley; Tetrazoles; Vasoconstriction; Vasodilator Agents | 1995 |
Characterization of PD 121981- and CGP 42112-induced unmasking of low concentration effects of angiotensin II in rabbit abdominal aorta.
Topics: Angiotensin II; Angiotensin Receptor Antagonists; Animals; Aorta, Abdominal; Biphenyl Compounds; Calcium; Dithiothreitol; Female; Gallic Acid; Imidazoles; Losartan; Male; Nifedipine; Oligopeptides; Pyridines; Rabbits; Tetrazoles; Vasoconstriction | 1994 |
Angiotensin subtype 1 blockade selectively potentiates adenosine subtype 2-mediated vasodilation.
Topics: Adenosine; Angiotensin II; Animals; Biphenyl Compounds; Blood Pressure; Heart Rate; Imidazoles; Injections, Intravenous; Losartan; Male; Nifedipine; Nitroglycerin; Rats; Rats, Sprague-Dawley; Tetrazoles; Vascular Resistance; Vasodilation | 1993 |
Regulation of the urinary excretion of endothelin in the rat.
Topics: Analysis of Variance; Angiotensin II; Animals; Antihypertensive Agents; Arginine Vasopressin; Biphenyl Compounds; Blood Pressure; Captopril; Dose-Response Relationship, Drug; Endothelins; Glomerular Filtration Rate; Imidazoles; Kidney; Losartan; Male; Nifedipine; Radioimmunoassay; Rats; Rats, Wistar; Saralasin; Tetrazoles | 1993 |
Mechanisms of angiotensin II chronotropic effect in anaesthetized dogs.
Topics: Adrenergic alpha-Antagonists; Adrenergic beta-Antagonists; Alkaloids; Anesthesia; Angiotensin II; Angiotensin Receptor Antagonists; Animals; Antihypertensive Agents; Biphenyl Compounds; Blood Pressure; Dogs; Female; Heart Rate; Imidazoles; Injections; Losartan; Male; Nifedipine; Receptors, Adrenergic, alpha; Sinoatrial Node; Staurosporine; Tetrazoles; Vagotomy; Vasoconstrictor Agents; Vasodilator Agents | 1995 |
Angiotensin II regulation of intracellular calcium in astroglia cultured from rat hypothalamus and brainstem.
Topics: Angiotensin II; Angiotensin Receptor Antagonists; Animals; Astrocytes; Biphenyl Compounds; Brain Stem; Cadmium; Caffeine; Calcium; Calcium Channel Blockers; Cells, Cultured; Dose-Response Relationship, Drug; Enzyme Inhibitors; Gadolinium; Hypothalamus; Imidazoles; Indoles; Losartan; Nifedipine; Phosphodiesterase Inhibitors; Pyridines; Rats; Rats, Sprague-Dawley; Receptors, Angiotensin; Ryanodine; Terpenes; Tetrazoles; Thapsigargin; Time Factors | 1996 |
Autoregulation of total and zonal glomerular filtration rate in spontaneously hypertensive rats during antihypertensive therapy.
Topics: Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Animals; Antihypertensive Agents; Biphenyl Compounds; Calcium Channel Blockers; Enalapril; Glomerular Filtration Rate; Hemodynamics; Homeostasis; Hypertension; Imidazoles; Losartan; Male; Nifedipine; Rats; Rats, Inbred SHR; Rats, Inbred WKY; Tetrazoles | 1996 |
Nifedipine, losartan and captopril effects on hyperplasia of vascular smooth muscle from Ren-2 transgenic rats.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Animals, Genetically Modified; Antihypertensive Agents; Biphenyl Compounds; Captopril; Hyperplasia; Imidazoles; Losartan; Muscle, Smooth, Vascular; Nifedipine; Rats; Rats, Sprague-Dawley; Tetrazoles | 1997 |
Effects of captopril, losartan, and nifedipine on cell hypertrophy of cultured vascular smooth muscle from hypertensive Ren-2 transgenic rats.
Topics: Angiotensin II; Animals; Animals, Genetically Modified; Biphenyl Compounds; Captopril; Cells, Cultured; Hypertension; Hypertrophy; Imidazoles; Losartan; Muscle, Smooth, Vascular; Nifedipine; Protein Biosynthesis; Rats; Rats, Sprague-Dawley; Renin; Tetrazoles | 1997 |
Measurement of left ventricular maximal isovolumetric pressure in rats: effects of antihypertensive drugs and diabetes mellitus.
Topics: Adrenergic alpha-Antagonists; Adrenergic beta-Antagonists; Angiotensin Receptor Antagonists; Animals; Antihypertensive Agents; Blood Pressure Determination; Calcium Channel Blockers; Catheterization; Diabetes Mellitus, Experimental; Female; Losartan; Metoprolol; Nifedipine; Prazosin; Rats; Rats, Sprague-Dawley; Reproducibility of Results; Ventricular Function, Left; Ventricular Pressure | 1998 |
Different pathways for Ca2+ mobilization by angiotensin II and carbachol in the circular muscle of the guinea-pig ileum.
Topics: Angiotensin II; Angiotensin Receptor Antagonists; Animals; Calcium; Calcium Channel Blockers; Carbachol; Electric Stimulation; Female; Guinea Pigs; Ileum; Imidazoles; In Vitro Techniques; Isradipine; Losartan; Male; Membrane Potentials; Muscarinic Agonists; Muscle Contraction; Muscle, Smooth; Nickel; Nifedipine; Potassium Chloride; Pyridines; Receptor, Angiotensin, Type 1; Receptor, Angiotensin, Type 2; Tetrodotoxin; Vasoconstrictor Agents; Verapamil | 1999 |
Apoptosis during regression of cardiac hypertrophy in spontaneously hypertensive rats. Temporal regulation and spatial heterogeneity.
Topics: Adrenergic beta-Antagonists; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Animals; Antihypertensive Agents; Apoptosis; Calcium Channel Blockers; Cardiomegaly; Data Interpretation, Statistical; DNA; DNA Fragmentation; Enalapril; Hemodynamics; Hydralazine; Losartan; Male; Nifedipine; Propranolol; Rats; Time Factors | 1999 |
Antihypertensive treatment in early postnatal life modulates prenatal dietary influences upon blood pressure in the rat.
Topics: Analysis of Variance; Angiotensin Receptor Antagonists; Animal Nutritional Physiological Phenomena; Animals; Antihypertensive Agents; Blood Pressure; Calcium Channel Blockers; Diet, Protein-Restricted; Female; Losartan; Male; Nifedipine; Pregnancy; Prenatal Exposure Delayed Effects; Rats; Rats, Wistar; Receptor, Angiotensin, Type 1 | 2000 |
Arterial responses in vitro and plasma digoxin immunoreactivity after losartan and enalapril treatments in experimental hypertension.
Topics: Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Animals; Antihypertensive Agents; Blood Pressure; Body Weight; Cardiomegaly; Digoxin; Dihydropyridines; Enalapril; Heart; Hypertension; Losartan; Male; Mesenteric Arteries; Muscle, Smooth, Vascular; Nifedipine; Organ Size; Potassium Chloride; Rats; Rats, Inbred SHR; Rats, Inbred WKY; Receptor, Angiotensin, Type 1; Receptor, Angiotensin, Type 2; Sodium-Potassium-Exchanging ATPase; Tunica Media | 2000 |
Angiotensin II mediates pressure loading-induced mitogen-activated protein kinase activation in isolated rat aorta.
Topics: Angiotensin II; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Animals; Aorta; Calcium; Calcium Channel Blockers; Captopril; Enzyme Activation; In Vitro Techniques; Ion Channel Gating; Losartan; Male; Mitogen-Activated Protein Kinases; Muscle, Smooth, Vascular; Nifedipine; Pepstatins; Rats; Rats, Wistar; Renin; Stress, Mechanical | 2000 |
Neuropeptide Y enhances potassium excretion by mechanisms distinct from those controlling sodium excretion.
Topics: Aldosterone; Animals; Bradykinin; Humans; Indomethacin; Losartan; Male; Neuropeptide Y; Nifedipine; Potassium; Rats; Rats, Wistar; Sodium | 2000 |
Modulation of the renin-angiotensin system may alter the adrenocortical regeneration.
Topics: Adrenal Cortex; Adrenalectomy; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Calcium Channel Blockers; Cell Division; Enalapril; Losartan; Male; Mitosis; Nifedipine; Rats; Rats, Wistar; Regeneration; Renin; Renin-Angiotensin System; Steroids | 2001 |
The mechanism of angiotensin II binding downregulation by high glucose in primary renal proximal tubule cells.
Topics: Angiotensin II; Animals; Antihypertensive Agents; Antioxidants; Calcium Channel Blockers; Carcinogens; Cells, Cultured; Dose-Response Relationship, Drug; Gene Expression; Glucose; Imidazoles; Iodine Radioisotopes; Kidney Tubules, Proximal; Lipid Peroxidation; Losartan; Nifedipine; Oxidants; Oxidative Stress; Protein Kinase C; Protein Synthesis Inhibitors; Pyridines; Rabbits; Radioligand Assay; Receptor, Angiotensin, Type 1; Receptors, Angiotensin; RNA, Messenger; Tetradecanoylphorbol Acetate; Transforming Growth Factor beta; Vasoconstrictor Agents | 2002 |
Endothelial factors and microvascular hypertensive disease.
Topics: Acetylcholine; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Animals; Antihypertensive Agents; Calcium Channel Blockers; Cilazapril; Dose-Response Relationship, Drug; Endothelium, Vascular; Humans; Hypertension; Lisinopril; Losartan; Nifedipine; Nitric Oxide; Rats; Rats, Inbred SHR; Vascular Resistance; Vasoconstriction; Vasodilator Agents | 2001 |
Effects of antihypertensive therapy on intrarenal angiotensin and bradykinin levels in experimental renal insufficiency.
Topics: Aldosterone; Angiotensin II; Animals; Antihypertensive Agents; Blood Pressure; Body Weight; Bradykinin; Creatinine; Enalapril; Kidney; Losartan; Male; Nephrectomy; Nifedipine; Proteinuria; Rats; Rats, Wistar; Renin; Renin-Angiotensin System; Vasodilator Agents | 2002 |
The effect of losartan on calcium uptake by bovine aortic media in vitro.
Topics: Angiotensin II; Angiotensin Receptor Antagonists; Animals; Aorta, Thoracic; Calcium; Calcium Channel Blockers; Cattle; Culture Techniques; Losartan; Muscle, Smooth, Vascular; Nifedipine; Receptor, Angiotensin, Type 1 | 2002 |
Effects of antihypertensive therapy on cardiac sodium/hydrogen ion exchanger activity and hypertrophy in spontaneously hypertensive rats.
Topics: Animals; Antihypertensive Agents; Blood Pressure; Calcium Channel Blockers; Cardiomegaly; Disease Models, Animal; Enalapril; Hypertension; Losartan; Male; Myocardium; Nifedipine; Rats; Rats, Wistar; Sodium-Hydrogen Exchangers | 2002 |
Persistent lowering of arterial pressure after continuous and intermittent therapy.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Antihypertensive Agents; Blood Pressure; Drug Therapy, Combination; Enalapril; Heart Rate; Heart Ventricles; Hydralazine; Hydrochlorothiazide; Hypertension; Losartan; Male; Nifedipine; Rats; Rats, Inbred SHR; Renin-Angiotensin System; Vasodilator Agents | 2003 |
Angiotensin II inhibition of Ca2+ currents is independent of ATR1 angiotensin II receptor activation in rat adult vagal afferent neurons.
Topics: Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Animals; Calcium Channel Blockers; Calcium Channels; Cells, Cultured; Drug Interactions; Losartan; Membrane Potentials; Neural Inhibition; Neurons, Afferent; Nifedipine; Nodose Ganglion; Patch-Clamp Techniques; Rats; Receptor, Angiotensin, Type 1; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Saralasin | 2005 |
Region-specific, pacing-induced changes in repolarization in rabbit atrium: an example of sensitivity to the rare.
Topics: Action Potentials; Adrenergic beta-Antagonists; Animals; Apamin; Atrial Fibrillation; Atropine; Calcium Channel Blockers; Calcium Channels, L-Type; Cardiac Pacing, Artificial; Coronary Vessels; Dogs; Electrocardiography; Female; Heart Atria; Heart Conduction System; Losartan; Nifedipine; Potassium Channel Blockers; Propranolol; Pulmonary Veins; Rabbits; Receptor, Angiotensin, Type 1; Receptors, Muscarinic; Ryanodine | 2005 |
Adrenergic origin of very low-frequency blood pressure oscillations in the unanesthetized rat.
Topics: Adrenergic Agonists; Adrenergic Antagonists; Animals; Arginine Vasopressin; Barium Sulfate; Blood Pressure; Calcium Channel Blockers; Consciousness; Epinephrine; Ganglionic Blockers; Hemodynamics; Hexamethonium; Losartan; Nifedipine; Norepinephrine; Potassium Channel Blockers; Prazosin; Propranolol; Rats; Rats, Inbred WKY; Receptors, Adrenergic; Vasoconstrictor Agents; Yohimbine | 2006 |
Impact of antihypertensive treatments on erectile responses in aging spontaneously hypertensive rats.
Topics: Aging; Animals; Antihypertensive Agents; Apomorphine; Blood Pressure; Enalapril; Hydralazine; Hydrochlorothiazide; Hypertension; Kidney Transplantation; Losartan; Male; Nifedipine; Penile Erection; Random Allocation; Rats; Rats, Inbred SHR; Testosterone | 2006 |
Role of angiotensin II in retinal leukostasis in the diabetic rat.
Topics: Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Animals; Blood Glucose; Blood Pressure; Calcium Channel Blockers; Concanavalin A; Diabetes Mellitus, Experimental; Diabetic Retinopathy; Intercellular Adhesion Molecule-1; Leukocyte Common Antigens; Leukostasis; Losartan; Male; Nifedipine; Protein Tyrosine Phosphatase, Non-Receptor Type 1; Ramipril; Rats; Rats, Long-Evans; Retina; Retinal Diseases | 2006 |
Beneficial effects of the combination of nifedipine and losartan in hypertensive Dahl salt-sensitive rats.
Topics: Angiotensin II Type 1 Receptor Blockers; Animals; Aorta; Blood Pressure; Calcium Channel Blockers; Drug Therapy, Combination; Gene Expression; Hypertension; Hypertrophy, Left Ventricular; Kidney; Losartan; Male; Natriuretic Peptide, Brain; Nifedipine; Organ Size; Rats; Rats, Inbred Dahl; RNA, Messenger; Sodium Chloride, Dietary; Transforming Growth Factor beta1 | 2007 |
Delayed effects of hypotensive drugs on structural characteristics of the renal glomerular system in hypertensive NISAG rats.
Topics: Animals; Antihypertensive Agents; Enalapril; Hypertension; Kidney Glomerulus; Losartan; Male; Nifedipine; Prazosin; Rats; Time Factors | 2007 |
Effects of antihypertensive drugs on capillary rarefaction in spontaneously hypertensive rats: intravital microscopy and histologic analysis.
Topics: Angiotensin II Type 1 Receptor Blockers; Animals; Antihypertensive Agents; Atenolol; Blood Pressure; Capillaries; Disease Models, Animal; Enalapril; Heart Ventricles; Hypertension; Losartan; Male; Microcirculation; Microscopy, Video; Muscle, Skeletal; Nifedipine; Rats; Rats, Inbred SHR; Rats, Inbred WKY; Skin | 2008 |
Sex differences in angiotensin signaling in bulbospinal neurons in the rat rostral ventrolateral medulla.
Topics: 3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl ester; Age Factors; Angiotensin II; Animals; Calcium Channels, L-Type; Calcium Signaling; Estradiol; Female; Losartan; Male; Medulla Oblongata; NADPH Oxidases; Neurons; Nifedipine; Ovariectomy; Patch-Clamp Techniques; Rats; Rats, Sprague-Dawley; Reactive Oxygen Species; Receptor, Angiotensin, Type 1; Sex Factors; Signal Transduction; Tyrosine 3-Monooxygenase | 2008 |
AT(1) receptor blockers increase insulin-like growth factor-I production by stimulating sensory neurons in spontaneously hypertensive rats.
Topics: Angiotensin II Type 1 Receptor Blockers; Animals; Benzimidazoles; Benzoates; Blood Pressure; Calcitonin Gene-Related Peptide; Capsaicin; Cells, Cultured; Ganglia, Spinal; Hypertension; Imidazoles; Insulin-Like Growth Factor I; Kidney; Losartan; Male; Myocardium; Nifedipine; Peptidyl-Dipeptidase A; Rats; Rats, Inbred SHR; Rats, Inbred WKY; Receptor, Angiotensin, Type 1; RNA, Messenger; Sensory Receptor Cells; Telmisartan; Tetrazoles; Valine; Valsartan; Vasodilator Agents | 2009 |
Production and secretion of adiponectin from 3T3-L1 adipocytes: comparison of antihypertensive drugs.
Topics: 3T3-L1 Cells; Adipocytes; Adiponectin; Animals; Antihypertensive Agents; Atenolol; Benzimidazoles; Benzoates; Captopril; Hydrochlorothiazide; Losartan; Mice; Nifedipine; RNA, Messenger; Telmisartan | 2009 |
Comparative study of vasodilators in an animal model of chronic volume overload caused by severe aortic regurgitation.
Topics: Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Animals; Aortic Valve Insufficiency; Captopril; Cardiomyopathy, Dilated; Chronic Disease; Disease Models, Animal; Dose-Response Relationship, Drug; Echocardiography, Doppler; Follow-Up Studies; Hypertrophy, Left Ventricular; Losartan; Male; Nifedipine; Rats; Rats, Wistar; Renin-Angiotensin System; Treatment Outcome; Vasodilator Agents; Ventricular Function, Left | 2009 |
Losartan and nifedipine therapy in patients with secondary pulmonary hypertension.
Topics: Anti-Arrhythmia Agents; Blood Pressure; Endothelium, Vascular; Humans; Hypertension, Pulmonary; Losartan; Nifedipine; Pulmonary Artery; Vasodilator Agents | 2010 |
Effects of anti-hypertensive drugs on esophageal body contraction.
Topics: Adult; Antihypertensive Agents; Atenolol; Calcium Channel Blockers; Esophagus; Gastrointestinal Motility; Humans; Losartan; Male; Muscle, Smooth; Nifedipine; Peristalsis; Sympatholytics | 2010 |
Availability, price and affordability of cardiovascular medicines: a comparison across 36 countries using WHO/HAI data.
Topics: Antihypertensive Agents; Atenolol; Captopril; Cardiovascular Diseases; Cost of Illness; Developing Countries; Health Services Accessibility; Humans; Hydrochlorothiazide; Losartan; Nifedipine; World Health Organization | 2010 |
Clinical pearls in general internal medicine.
Topics: Abdominal Pain; Adrenergic alpha-1 Receptor Antagonists; Adult; Aged; Androgen Antagonists; Anti-Infective Agents, Urinary; Antihypertensive Agents; Calcium Channel Blockers; Creatinine; Diagnosis, Differential; Female; Fenofibrate; Gout; Humans; Hypoglycemic Agents; Hypolipidemic Agents; Internal Medicine; Losartan; Male; Metformin; Nifedipine; Potassium; Sulfonamides; Tamsulosin; Trimethoprim; Ureteral Calculi; Vitamin B 12 Deficiency | 2011 |
Chronic vasodilation increases renal medullary PDE5A and α-ENaC through independent renin-angiotensin-aldosterone system pathways.
Topics: Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Animals; Blood Pressure; Cyclic Nucleotide Phosphodiesterases, Type 5; Diuretics; Enalapril; Epithelial Sodium Channels; Female; Kidney Medulla; Losartan; Nephrons; Nifedipine; Pregnancy; Rats; Rats, Sprague-Dawley; Renin-Angiotensin System; Sodium; Sodium Nitrite; Spironolactone; Vasodilation; Vasodilator Agents | 2013 |
Metabolic approaches to antihypertensive treatment in diabetic patients.
Topics: Angiotensin II Type 1 Receptor Blockers; Antihypertensive Agents; Benzimidazoles; Benzoates; Calcium Channel Blockers; Diabetes Mellitus, Type 2; Diuretics; Female; Humans; Hydrochlorothiazide; Hypertension; Insulin Resistance; Losartan; Male; Nifedipine | 2015 |
Hypotensive and antihypertensive effects of a hydroalcoholic extract from Senecio nutans Sch. Bip. (Compositae) in mice: Chronotropic and negative inotropic effect, a nifedipine-like action.
Topics: Animals; Antihypertensive Agents; Blood Pressure; Dose-Response Relationship, Drug; Electrocardiography; Ethnopharmacology; Heart Atria; Heart Rate; Hypertension; Losartan; Male; Mice; Myocardial Contraction; Nifedipine; Papillary Muscles; Plant Extracts; Rats; Senecio | 2016 |
Prediction of drug interaction between oral adsorbent AST-120 and concomitant drugs based on the in vitro dissolution and in vivo absorption behavior of the drugs.
Topics: Administration, Oral; Adsorption; Aluminum Hydroxide; Amlodipine; Aspirin; Carbon; Drug Interactions; Glycine; Humans; Intestinal Absorption; Losartan; Magnesium; Metoprolol; Models, Biological; Nifedipine; Oxides; Renal Insufficiency, Chronic; Solubility; Triazolam | 2016 |
Clinical efficacy of various anti-hypertensive regimens in hypertensive women of Punjab; a longitudinal cohort study.
Topics: Aged; Antihypertensive Agents; Blood Pressure; Calcium Channel Blockers; Cohort Studies; Diuretics; Drug Therapy, Combination; Female; Humans; Hydrochlorothiazide; Hypertension; Longitudinal Studies; Losartan; Male; Middle Aged; Nifedipine; Pakistan; Treatment Outcome | 2020 |
Antihypertensive medicine use differs between Ghana and Nigeria.
Topics: Amlodipine; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Calcium Channel Blockers; Ghana; Humans; Hypertension; Lisinopril; Losartan; Nifedipine; Nigeria | 2022 |